Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate the experimental medication BMS-986224 in participants with varying levels of renal function.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Bristol-Myers Squibb
NCT06532890 · Cardiac Failure, Graft Rejection
NCT06503016 · Hypotension, Consciousness, Level Altered, and more
NCT06918301 · Cardiac Failure Acute, Hemodynamic Monitoring
NCT05761639 · Cardiac Failure
NCT00610051 · End Stage Cardiac Failure, HFrEF - Heart Failure With Reduced Ejection Fraction, and more
Clinical Pharmacology of Miami
Miami, Florida
Orlando Clinical Research Center
Orlando, Florida
Prism Research
Saint Paul, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions